MATTHEW TOMM: Open Payments
NPI 1336768050 · LONE TREE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$645 in 22 payments from 8 companies in 2025. Trend: 2023 $504 · 2024 $417 · 2025 $645
Food & beverage: $645
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $274 |
| GlaxoSmithKline, LLC. | 6 | $221 |
| ABBVIE INC. | 2 | $39 |
| Amgen Inc. | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, VOQUEZNA, GEMTESA, Xtandi, LUPRON DEPOT, BOTOX.
Industry payments across CO — which companies pay providers there.
